Molekule Group, Inc. Increase (Decrease) in Accounts Payable
Molekule Group, Inc. reported Increase (Decrease) in Accounts Payable of -$8.75 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2023-08-14
- Molekule Group, Inc. increase (decrease) in accounts payable for the quarter ending 2023-06-30 was -$4.23M, a 1783.40% decline year-over-year.
- Molekule Group, Inc. increase (decrease) in accounts payable for the quarter ending 2023-03-31 was -$4.51M.
- Molekule Group, Inc. increase (decrease) in accounts payable for the quarter ending 2022-12-31 was $2.37M, a 1058.73% increase year-over-year.
- Molekule Group, Inc. increase (decrease) in accounts payable for the quarter ending 2022-09-30 was $166.53K, a 17.46% increase year-over-year.
- Molekule Group, Inc. increase (decrease) in accounts payable for fiscal 2022 was $2.29M, a 285.28% increase from fiscal 2021.
- Molekule Group, Inc. increase (decrease) in accounts payable for fiscal 2021 was $595.12K, a 217.66% increase from fiscal 2020.
- Molekule Group, Inc. increase (decrease) in accounts payable for fiscal 2020 was $187.35K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$4.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$8.75M 10-Q · filed 2023-08-14 | -$6.38M derived: sum of 3 quarters · filed 2023-08-14 | -$6.21M derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | -$4.51M 10-Q · filed 2023-05-15 | -$2.15M derived: sum of 2 quarters · filed 2023-05-15 | -$1.98M derived: sum of 3 quarters · filed 2023-05-15 | -$1.73M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $2.37M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-04-03 | $2.53M derived: sum of 2 quarters · filed 2023-04-03 | $2.78M derived: sum of 3 quarters · filed 2023-08-14 | $2.29M 10-K/A · filed 2023-04-03 |
| 2022-09-30 | $166.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $417.93K derived: sum of 2 quarters · filed 2023-08-14 | -$72.90K 10-Q · filed 2022-11-14 | $131.27K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | $251.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$239.43K 10-Q · filed 2023-08-14 | -$35.26K derived: sum of 3 quarters · filed 2023-08-14 | $106.51K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$490.83K 10-Q · filed 2023-05-15 | -$286.66K derived: sum of 2 quarters · filed 2023-05-15 | -$144.88K derived: sum of 3 quarters · filed 2023-05-15 | -$57.73K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $204.17K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-04-03 | $345.94K derived: sum of 2 quarters · filed 2023-04-03 | $433.10K derived: sum of 3 quarters · filed 2023-04-03 | $595.12K 10-K/A · filed 2023-04-03 |
| 2021-09-30 | $141.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $228.93K derived: sum of 2 quarters · filed 2022-11-14 | $390.95K 10-Q · filed 2022-11-14 | $292.52K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $87.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $249.18K 10-Q · filed 2022-08-15 | $150.75K derived: sum of 3 quarters · filed 2022-08-15 | |
| 2021-03-31 | $162.02K 10-Q · filed 2022-05-12 | $63.59K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$98.43K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-04-01 | $187.35K 10-K · filed 2022-04-01 | ||
| 2020-09-30 | $285.78K 10-Q/A · filed 2022-02-07 |